Serum concentrations of dehydroepiandrosterone and dehydroepiandrosterone sulfate and their relation to cytokine production during and after normal pregnancy. 2004

Noriko Tagawa, and Yoh Hidaka, and Toru Takano, and Yuki Shimaoka, and Yoshiharu Kobayashi, and Nobuyuki Amino
Clinical Chemistry Laboratory, Kobe Pharmaceutical University, 658-8558 Kobe, Japan. t-noriko@kobepharma-u.ac.jp

BACKGROUND Since dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) have been suggested to have immunoregulatory effects, changes in the levels of these substances during and after pregnancy might affect the maternal immune system. We examined serum concentrations of DHEA and DHEAS, and cytokine production during pregnancy and after delivery. METHODS The subjects were 73 normal pregnant, 76 normal postpartum and 30 normal non-pregnant women. Whole-blood was stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin and the levels of cytokines in the supernatant were measured using enzyme-linked immunosorbent assay (ELISA). DHEA and DHEAS were measured using ELISA and gas chromatography-mass spectrometry (GC-MS), respectively. RESULTS The serum DHEA levels increased in the first and in the second trimesters and decreased after delivery until 11 months postpartum. DHEAS levels were decreased in the second and in the third trimesters and returned to non-pregnant levels after pregnancy. All measured cytokines (IFN-gamma, IL-2, IL-4 and IL-10) were decreased during pregnancy and subsequently increased postpartum. We found significant negative correlations between DHEA and cytokine levels. CONCLUSIONS Increase of serum DHEA in the first and the second trimesters may suppress immune reaction during pregnancy, while a decrease of DHEA after delivery may induce postpartum enhancement of the maternal immune system. DHEA may be involved in modifying the maternal immune responses during and after pregnancy.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D003687 Dehydroepiandrosterone A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion. Dehydroisoandrosterone,Prasterone,5-Androsten-3-beta-hydroxy-17-one,5-Androsten-3-ol-17-one,Androstenolone,DHEA,Prasterone, 3 alpha-Isomer,5 Androsten 3 beta hydroxy 17 one,5 Androsten 3 ol 17 one,Prasterone, 3 alpha Isomer
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D019314 Dehydroepiandrosterone Sulfate The circulating form of a major C19 steroid produced primarily by the ADRENAL CORTEX. DHEA sulfate serves as a precursor for TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. DHEA Sulfate,DHA Sulfate,Dehydroisoandrosterone Sulfate,Prasterone Sulfate,Sulfate, DHA,Sulfate, DHEA,Sulfate, Dehydroepiandrosterone,Sulfate, Dehydroisoandrosterone,Sulfate, Prasterone

Related Publications

Noriko Tagawa, and Yoh Hidaka, and Toru Takano, and Yuki Shimaoka, and Yoshiharu Kobayashi, and Nobuyuki Amino
January 1991, Epidemiologic reviews,
Noriko Tagawa, and Yoh Hidaka, and Toru Takano, and Yuki Shimaoka, and Yoshiharu Kobayashi, and Nobuyuki Amino
June 1990, The Journal of clinical endocrinology and metabolism,
Noriko Tagawa, and Yoh Hidaka, and Toru Takano, and Yuki Shimaoka, and Yoshiharu Kobayashi, and Nobuyuki Amino
September 2000, American journal of reproductive immunology (New York, N.Y. : 1989),
Noriko Tagawa, and Yoh Hidaka, and Toru Takano, and Yuki Shimaoka, and Yoshiharu Kobayashi, and Nobuyuki Amino
March 1975, The Journal of clinical endocrinology and metabolism,
Noriko Tagawa, and Yoh Hidaka, and Toru Takano, and Yuki Shimaoka, and Yoshiharu Kobayashi, and Nobuyuki Amino
March 2003, Metabolism: clinical and experimental,
Noriko Tagawa, and Yoh Hidaka, and Toru Takano, and Yuki Shimaoka, and Yoshiharu Kobayashi, and Nobuyuki Amino
November 1995, The Journal of clinical endocrinology and metabolism,
Noriko Tagawa, and Yoh Hidaka, and Toru Takano, and Yuki Shimaoka, and Yoshiharu Kobayashi, and Nobuyuki Amino
February 1988, Zhonghua yi xue za zhi,
Noriko Tagawa, and Yoh Hidaka, and Toru Takano, and Yuki Shimaoka, and Yoshiharu Kobayashi, and Nobuyuki Amino
April 2000, Clinical chemistry,
Noriko Tagawa, and Yoh Hidaka, and Toru Takano, and Yuki Shimaoka, and Yoshiharu Kobayashi, and Nobuyuki Amino
September 1987, The Journal of clinical endocrinology and metabolism,
Noriko Tagawa, and Yoh Hidaka, and Toru Takano, and Yuki Shimaoka, and Yoshiharu Kobayashi, and Nobuyuki Amino
June 1983, Clinical chemistry,
Copied contents to your clipboard!